rhodamine 123 has been researched along with Disease Exacerbation in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andelković, T; Banković, J; Pešić, M; Podolski-Renić, A; Ruždijić, S; Tanić, N | 1 |
Benoit, Y; De Moerloose, B; Demarche, M; Devalck, C; Dhooge, C; Laureys, G; Leroy, J; Philippé, J; Plantaz, D | 1 |
2 other study(ies) available for rhodamine 123 and Disease Exacerbation
Article | Year |
---|---|
The role of paclitaxel in the development and treatment of multidrug resistant cancer cell lines.
Topics: ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Cycle; Cell Death; Cell Line, Tumor; Colonic Neoplasms; Disease Progression; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Glioblastoma; Glutathione; Humans; Inactivation, Metabolic; Paclitaxel; Rhodamine 123; RNA, Messenger; Vascular Endothelial Growth Factor A | 2011 |
Discrepant flow cytometric expression and function of P-glycoprotein in neuroblastic tumors.
Topics: Adolescent; Adult; ATP Binding Cassette Transporter, Subfamily B, Member 1; Child; Child, Preschool; Disease Progression; Female; Flow Cytometry; Ganglioneuroma; Humans; Immunohistochemistry; Infant; Infant, Newborn; Leukocyte Common Antigens; Male; Neoplasm Proteins; Neuroblastoma; Rhodamine 123; Tumor Cells, Cultured | 1999 |